Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023

BUY
$3.78 - $11.99 $55,906 - $177,332
14,790 New
14,790 $58,000
Q2 2023

Jul 18, 2023

SELL
$7.93 - $13.82 $1,697 - $2,957
-214 Reduced 1.41%
14,934 $158,000
Q1 2023

Apr 13, 2023

SELL
$7.65 - $10.38 $1,162 - $1,577
-152 Reduced 0.99%
15,148 $126,000
Q4 2022

Jan 23, 2023

BUY
$7.07 - $15.69 $108,171 - $240,057
15,300 New
15,300 $141 Million

Others Institutions Holding STOK

About Stoke Therapeutics, Inc.


  • Ticker STOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,419,300
  • Market Cap $474M
  • Description
  • Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...
More about STOK
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.